Enhanced Antibacterial Activity of Dermaseptin through Its Immobilization on Alginate Nanoparticles-Effects of Menthol and Lactic Acid on Its Potentialization
Dermaseptin B2 (DRS-B2) is an antimicrobial peptide secreted by <i>Phyllomedusa bicolor</i>, which is an Amazonian tree frog. Here, we show that the adsorption of DRS-B2 on alginate nanoparticles (Alg NPs) results in a formulation (Alg NPs + DRS-B2) with a remarkable antibacterial activi...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_c23a315e3adf40a6ab0ddd60976c17d6 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Noura Hazime |e author |
700 | 1 | 0 | |a Yanath Belguesmia |e author |
700 | 1 | 0 | |a Alexandre Barras |e author |
700 | 1 | 0 | |a Mohamed Amiche |e author |
700 | 1 | 0 | |a Rabah Boukherroub |e author |
700 | 1 | 0 | |a Djamel Drider |e author |
245 | 0 | 0 | |a Enhanced Antibacterial Activity of Dermaseptin through Its Immobilization on Alginate Nanoparticles-Effects of Menthol and Lactic Acid on Its Potentialization |
260 | |b MDPI AG, |c 2022-06-01T00:00:00Z. | ||
500 | |a 10.3390/antibiotics11060787 | ||
500 | |a 2079-6382 | ||
520 | |a Dermaseptin B2 (DRS-B2) is an antimicrobial peptide secreted by <i>Phyllomedusa bicolor</i>, which is an Amazonian tree frog. Here, we show that the adsorption of DRS-B2 on alginate nanoparticles (Alg NPs) results in a formulation (Alg NPs + DRS-B2) with a remarkable antibacterial activity against <i>Escherichia coli</i> ATCC 8739 and <i>E. coli</i> 184 strains, which are sensitive and resistant, respectively, to colistin. The antibacterial activity, obtained with this new formulation, is higher than that obtained with DRS-B2 alone. Of note, the addition of lactic acid or menthol to this new formulation augments its antibacterial activity against the aforementioned Gram-negative bacilli. The safety of DRS-B2, and also that of the new formulation supplemented or not with a small molecule such as lactic acid or menthol has been proven on the human erythrocytes and the eukaryotic cell line types HT29 (human) and IPEC-1 (animal). Similarly, their stability was determined under the conditions mimicking the gastrointestinal tract with different conditions: pH, temperature, and the presence of digestive enzymes. Based on all the obtained data, we assume that these new formulations are promising and could be suggested, after <i>in vivo</i> approval and completing regulation aspects, as alternatives to antibiotics to fight infections caused by Gram-negative bacilli such as <i>E. coli</i>. | ||
546 | |a EN | ||
690 | |a dermaseptin | ||
690 | |a DRS-B2 | ||
690 | |a alginate nanoparticles | ||
690 | |a menthol | ||
690 | |a lactic acid | ||
690 | |a synergy | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Antibiotics, Vol 11, Iss 6, p 787 (2022) | |
787 | 0 | |n https://www.mdpi.com/2079-6382/11/6/787 | |
787 | 0 | |n https://doaj.org/toc/2079-6382 | |
856 | 4 | 1 | |u https://doaj.org/article/c23a315e3adf40a6ab0ddd60976c17d6 |z Connect to this object online. |